Tumor pH-triggered “charge conversion” nanocarriers with on-demand drug release for precise cancer therapy
The pHe-triggered “charge conversion” nanocarriers were developed for combined X-ray-induced photodynamic therapy (X-PDT) and hypoxia-activated chemotherapy.
Keyword(s):
2020 ◽
Vol 27
(23)
◽
pp. 3877-3887
Keyword(s):
2020 ◽
Vol 30
(23)
◽
pp. 2001832
◽
Keyword(s):
Keyword(s):
Keyword(s):